ScholarIQanswers from OpenAlex & ORCID
Erik A. Imel
ResearcherPublications, citations & collaboration network
Erik A. Imel is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Erik A. Imel have?
ScholarIQindexed works
Erik A. Imel has 226 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Erik A. Imel have?
ScholarIQcitation count
Erik A. Imel has 8,271 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Erik A. Imel?
ScholarIQh-index
Erik A. Imel has an h-index of 45 in OpenAlex.
What is the i10-index of Erik A. Imel?
ScholarIQi10-index
Erik A. Imel has an i10-index of 87 in OpenAlex.
What is the ORCID of Erik A. Imel?
ScholarIQorcid
The ORCID for Erik A. Imel is on the source record.
What is the OpenAlex record for Erik A. Imel?
ScholarIQopenalex
The OpenAlex for Erik A. Imel is on the source record.
What are the most-cited papers on Erik A. Imel?
ScholarIQmost cited works
A clinician's guide to X-linked hypophosphatemia
Thomas O. Carpenter, Erik A. Imel, Ingrid A. Holm, Suzanne M. Jan de Beur, Karl Insogna
Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects
Y. Yamazaki, Akihiro Imura, Itaru Urakawa, Takashi Shimada, Junko Murakami, Yukiko Aono, Hisashi Hasegawa, Takeyoshi Yamashita, Kimihiko Nakatani, Yoshihiko Saito, Nozomi Okamoto, Norio Kurumatani, Noriyuki Namba, Taichi Kitaoka, Keiichi Ozono, Tomoyuki Sakai, Hiroshi Hataya, Shoji Ichikawa, Erik A. Imel, Michael J. Econs, Y Nabeshima
A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis
Shoji Ichikawa, Erik A. Imel, Mary L. Kreiter, Xijie Yu, Donald S. Mackenzie, Andrea H. Sorenson, Regina Goetz, Moosa Mohammadi, Kenneth E. White, Michael J. Econs
Burosumab Therapy in Children with X-Linked Hypophosphatemia
Thomas O. Carpenter, Michael P. Whyte, Erik A. Imel, Annemieke M. Boot, Wolfgang Högler, Agnès Linglart, Raja Padidela, William van’t Hoff, Meng Mao, Chao-Yin Chen, Alison Skrinar, Emil Kakkis, Javier San Martín, Anthony A. Portale
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
Erik A. Imel, Francis H. Glorieux, Michael P. Whyte, Craig F. Munns, Leanne M. Ward, Ola Nilsson, Jill H. Simmons, Raja Padidela, Noriyuki Namba, Hae Il Cheong, Pisit Pitukcheewanont, Etienne Sochett, Wolfgang Högler, Koji Muroya, Hiroyuki Tanaka, Gary S. Gottesman, Andrew Biggin, Farzana Perwad, Meng Mao, Chao-Yin Chen, Alison Skrinar, Javier San Martín, Anthony A. Portale